Gemvax Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Gemvax General Information

Description

Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.

Contact Information

Website
www.gemvax.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
VaxOnco
Corporate Office
  • Teknologisenteret
  • Kjølnes Ring
  • 3918 Porsgrunn
  • Norway

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemvax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gemvax‘s full profile, request access.

Request a free trial

Gemvax Patents

Gemvax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150125438-A1 Anti-inflammatory peptides and composition comprising the same Inactive 20-Jul-2012 0000000000 0
US-20150099693-A1 Anti-inflammatory peptides and composition comprising the same Active 11-May-2012 000000000 0
US-20150099692-A1 Anti-inflammatory peptides and composition comprising the same Active 11-May-2012 000000000 0
AU-2002307645-A1 Polypeptides derived from human telomerase reverse transcriptase Inactive 21-May-2001
US-20040235175-A1 Using eletroporation to transfer tumor rna sequences into cells; generating anticancer vaccine; immunotherapy; antisense agents Inactive 04-May-2001 C12N15/87 0
To view Gemvax’s complete patent history, request access »

Gemvax Executive Team (2)

Name Title Board Seat Contact Info
Seok-Jun Lee Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Gemvax Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gemvax‘s full profile, request access.

Request a free trial

Gemvax Subsidiaries (1)

Company Name Industry Location Founded
Flask Company Construction and Engineering Daejeon, South Korea 0000
To view Gemvax’s complete subsidiaries history, request access »

Gemvax FAQs

  • When was Gemvax founded?

    Gemvax was founded in 2001.

  • Who is the founder of Gemvax?

    Jon Eriksen is the founder of Gemvax.

  • Who is the CEO of Gemvax?

    Seok-Jun Lee is the CEO of Gemvax.

  • Where is Gemvax headquartered?

    Gemvax is headquartered in Porsgrunn, Norway.

  • What industry is Gemvax in?

    Gemvax’s primary industry is Drug Discovery.

  • Is Gemvax a private or public company?

    Gemvax is a Private company.

  • What is Gemvax’s current revenue?

    The current revenue for Gemvax is 00000.

  • Who are Gemvax’s investors?

    Pharmexa has invested in Gemvax.

  • When was Gemvax acquired?

    Gemvax was acquired on 30-Oct-2008.

  • Who acquired Gemvax?

    Gemvax was acquired by VaxOnco.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »